Post-op CXL pain linked to age


Collagen cross-linking (CXL) can cause more intense postoperative pain in younger patients.

Collagen cross-linking (CXL) can cause more intense postoperative pain in younger patients, according to a paper published in Cornea.

Dr Vinícius Ghanem et al., Cornea Department, Sadalla Amin Ghanem Eye Hospital, Joinville, Brazil, conducted a prospective study on 178 consecutive eyes of 135 patients with progressive keratoconus who underwent CXL.

The need for analgaesia with 30 mg of codeine and subjective self-evaluation was used to assess postoperative pain. Subjective evaluation was completed using the Wong-Baker FACES Pain Rating Scale at the end of each postoperative (PO) day for five days. The correlation between postoperative pain/keratometric readings and central corneal thickness (CCT) was assessed preoperatively.

The results revealed the mean number of codeine pills administered was 0.94, 0.72 and 0.28 at iPO, PO1 and PO2, respectively. There was a significant link between age and pain at PO3 and PO4 and between age and number of codeine pills on iPO. However, there was no significant association between mean overall pain and preoperative apical keratometry and pachymetry readings.

After CXL, pain is especially intense in particular during the first three postoperative days, despite aggressive pain control regimens. However, on each consecutive day, pain and the need for analgaesia decreased significantly.

The abstract can be viewed here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.